KR940004811B1 - Process for preparing benzoxazine derivatives - Google Patents

Process for preparing benzoxazine derivatives Download PDF

Info

Publication number
KR940004811B1
KR940004811B1 KR1019910014345A KR910014345A KR940004811B1 KR 940004811 B1 KR940004811 B1 KR 940004811B1 KR 1019910014345 A KR1019910014345 A KR 1019910014345A KR 910014345 A KR910014345 A KR 910014345A KR 940004811 B1 KR940004811 B1 KR 940004811B1
Authority
KR
South Korea
Prior art keywords
formula
compound
cpd
reacted
carboxylic acid
Prior art date
Application number
KR1019910014345A
Other languages
Korean (ko)
Inventor
박상후
김찬우
Original Assignee
주식회사 코오롱
하기주
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 코오롱, 하기주 filed Critical 주식회사 코오롱
Priority to KR1019910014345A priority Critical patent/KR940004811B1/en
Application granted granted Critical
Publication of KR940004811B1 publication Critical patent/KR940004811B1/en

Links

Landscapes

  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

A method for preparing 9-halo-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de [1,4 benzoxazine-6-carboxylic acid derivs. of formula (I) comprises: (a) reacting a cpd. of formula (II) with dialkyl alkoxy methylene malonate of formula (III) to obtain a cpd. of formula (IV); (b) cyclizing (IV) in diphenylether solvent at 150-250 deg.C for 2-4 hrs.; (c) reacting the obtd. cpd. with a cpd. of formula (V); (d) hydrolyzing the obtd. cpd.; and (e) reacting the obtd. cpd. with AH. The catalyst of the cyclization reaction is pref. polyphosphoric acid or its acid ester. In the formulas, R = H or C1-6 alkyl; R1 = C1-2 alkyl; X = halogen; A = mono-, di- or ring-substd. amino gp. The cpds. (I) is useful as an antibacterial agent.

Description

벤즈옥사진 유도체의 제조방법Method for preparing benzoxazine derivatives

본 발명은 항균제로 사용되는 다음 일반식(Ⅸ)의 9-할로-7-옥소-2,3-디하이드로-7H-피리도[1,2,3-d.e][1,4]-벤즈옥사진-6-카르복실산 유도체와 제약상으로 허용되는 그 염의 제조방법에 관한 것이다.The present invention provides 9-halo-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de] [1,4] -benzox of the following general formula used as an antimicrobial agent It relates to a photo-6-carboxylic acid derivative and a method for preparing a pharmaceutically acceptable salt thereof.

상기식에서 X는 할로겐 원자를 나타내며, R은 수소원자 또는 탄소수 1-6의 저급알킬기를 나타내며, A는 단일 치환된 아미노기, 이(디) 치환된 아미노기, 또는 다른 헤테로원자를 함유하는 환상 치환 아미노기를 나타낸다.Wherein X represents a halogen atom, R represents a hydrogen atom or a lower alkyl group of 1 to 6 carbon atoms, and A represents a cyclic substituted amino group containing a single substituted amino group, a di (di) substituted amino group, or another hetero atom Indicates.

단일치환된 아미노기의 예로서 모노에틸 아미노기, 모노메틸아미노기를 포함하며, 이치환된 아미노기의 예로서 디메틸아미노기, 디에틸아미노기를 포함하며, 환상치환아미노기로서는 4-7원환을 가지는 아미노기를 뜻하며, 그 예로서 아제티디닐, 피롤리디닐, 모르포리닐, 피페라지닐 및 호모피페라지닐이 포함되며, 보다 상세하게는 4-메틸-1-피페라지닐, 1-피페라지닐, 1-피롤리디닐, 3-히드록시-1-피롤리디닐, 1-피페리디닐, 4-히드록시-1-피페리디닐, 3-히드록시-1-피페리디닐, 4-모르포리닐, 4-(2-히드록시에틸)피페라지닐, 3,5-디메틸-1-피페라지닐, 4-디메틸아미노-1-피페라지닐, 호모피페라지닐, 1-피라졸리딜, 2-메틸-1-피라졸리딜 등을 의미한다.Examples of monosubstituted amino groups include monoethyl amino groups and monomethylamino groups, examples of di-substituted amino groups include dimethylamino groups and diethylamino groups, and cyclic substituted amino groups mean amino groups having 4-7 membered rings. Azetidinyl, pyrrolidinyl, morpholininyl, piperazinyl and homopiperazinyl, more specifically 4-methyl-1-piperazinyl, 1-piperazinyl, 1-pyrrolidinyl , 3-hydroxy-1-pyrrolidinyl, 1-piperidinyl, 4-hydroxy-1-piperidinyl, 3-hydroxy-1-piperidinyl, 4-morpholinyl, 4- (2 -Hydroxyethyl) piperazinyl, 3,5-dimethyl-1-piperazinyl, 4-dimethylamino-1-piperazinyl, homopiperazinyl, 1-pyrazolidyl, 2-methyl-1-pyra Zolidyl and the like.

본 발명의 화합물은 염산, 황산, 메탄술폰산 등과 같은 무기 또는 유기산과 산부가염을 생성할 수 있으며, 나트륨, 칼륨등과 해당 카르복실산 염을 생성할 수 있다.The compounds of the present invention can produce acid addition salts with inorganic or organic acids such as hydrochloric acid, sulfuric acid, methanesulfonic acid, and the like, and can produce sodium, potassium, and the like carboxylic acid salts.

본 발명의 화합물에 대한 제조방법으로서 대한민국 특허공고 제84-2141호의 내용은 다음의 방법으로 목적화합물을 제조하는 것이 공개되어 있다.As a preparation method for the compound of the present invention, Korean Patent Publication No. 84-2141 discloses the preparation of the target compound by the following method.

이러한 종래의 제조방법은 벤즈옥사진 링구조의 형성을 위하여 까다로운 조건에서 반응이 이루어지는 수소첨가반응을 거치는 고리화반응과 퀴놀린 링구조의 형성을 이루는 고리화반응의 두단계의 고리화 반응을 수행하는 등의, 출발물질로부터 6단계의 제조공정을 거쳐서 제조하는 방법으로 반응경로가 길어서 비효과적이며, 수소첨가반응 및 까다로운 분리공정을 거쳐야 한다.This conventional manufacturing method is to perform a two-step cyclization reaction of the cyclization reaction to form a benzoxazine ring structure and the cyclization reaction through a hydrogenation reaction in which the reaction is carried out under difficult conditions to form a quinoline ring structure It is a method of producing a six-step manufacturing process from the starting material, such as a long reaction path is ineffective, and must undergo a hydrogenation reaction and a difficult separation process.

본 발명자들은 오랜 연구를 행한 결과, 짧은 경로와 높은 순도의 화합물을 (Ⅸ)의 제조방법을 개발하였으며, 본 발명의 반응경로를 반응식으로 나타내면 다음과 같다.As a result of long research, the inventors of the present invention have developed a method for preparing a short route and a high purity compound (i), and the reaction route of the present invention is represented by the following reaction scheme.

본 발명을 보다 상세히 기술하면, 일반식(Ⅰ)의 화합물을 일반식(Ⅱ)의 디에틸 에톡시메틸렌말로네이트, 혹은 디메틸 메톡시메틸렌말로네이트와 반응시켜 일반식(Ⅲ)의 화합물을 얻는다.In more detail, the compound of formula (I) is reacted with diethyl ethoxymethylenemalonate of formula (II) or dimethyl methoxymethylenemalonate to obtain a compound of formula (III).

이때 반응조건은 용매존재하에서 또는 용매없이 직접 일반식(Ⅰ)과 (Ⅱ)의 화합물을 100도 내지 200도의 온도에서 2-4시간 정도 반응시킨 후 상온으로 냉각시켜 생성된 고체를 얻고 여기에 디페닐에테르와 같은 높은 비등점을 가지는 용매를 사용하여 150도 내지 250도의 온도에서 2-4시간 정도 고리화반응을 시킨후 상온으로 냉각하여 일반식(Ⅳ)의 화합물을 얻는다.In this case, the reaction conditions are obtained by reacting the compounds of the general formulas (I) and (II) for 2-4 hours at a temperature of 100 ° C. to 200 ° C., in the presence or absence of a solvent, and then cooling them to room temperature to obtain a solid. Using a solvent having a high boiling point such as phenyl ether, the reaction is cyclized at a temperature of 150 to 250 degrees for 2 to 4 hours, and then cooled to room temperature to obtain a compound of formula (IV).

고리화반응시 폴리포스포릭산 혹은 그 에스테르를 촉매 또는 용매로서 사용할 수 있다.In the cyclization reaction, polyphosphoric acid or its ester can be used as a catalyst or a solvent.

얻어진 일반식(Ⅳ)의 화합물을 일반식(Ⅴ)의 화합물과 반응시키면, 일반식(Ⅳ)의 화합물이 얻어지며, 이때 용매로서는 극성용매이면서 비등점이 높은 디메틸포름아미드가 바람직하며, 몰비로 5내지 10배의 산수용체를 사용하여 90 내지 150도 정도에서 20-30시간 반응시킨후 냉각하여 일반식(Ⅵ)의 화합물이 얻어진다.When the obtained compound of formula (IV) is reacted with a compound of formula (V), a compound of formula (IV) is obtained, wherein as the solvent, dimethylformamide having a high boiling point and a polar solvent is preferable, and the molar ratio is 5 After the reaction was carried out at about 90 to 150 degrees for 20 to 30 hours using an acid acceptor of 10 to 10 times, cooling to obtain a compound of the general formula (VI).

여기에서 일반식(Ⅴ)의 화합물은 일반식(Ⅳ)의 화합물에 대해서 몰비로 1 내지 5배를 사용할 수 있으며, 산수용체로서는 탄산칼륨, 탄산나트륨과 같은 알카리금속의 탄산염, 중탄산염 등이 바람직하다.Herein, the compound of formula (V) may be used in a molar ratio of 1 to 5 times with respect to the compound of formula (IV). As the acid acceptor, carbonates, bicarbonates and the like of alkali metals such as potassium carbonate and sodium carbonate are preferable.

일반식(Ⅵ)의 화합물을 가수분해하여 일반식(Ⅶ)의 화합물을 얻는데 가수분해조건으로는 산 또는 염기 조건하에 모두 가능하며, 물, 디옥산 및 이들의 혼합용매에서 수산화나트륨, 수산화칼륨등과 같은 염기로서 60도 내지 120도 정도에서 1-3시간 정도 반응시킨 후, 혼합물을 냉각하여 초산 또는 염산으로 처리하여 여과, 추출, 증발, 재결정 및 이들의 조합된 기술의 방법으로 수수한 화합물(Ⅶ)을 얻는다.The compound of formula (VI) is hydrolyzed to obtain a compound of formula (VII). The hydrolysis conditions are all possible under acidic or basic conditions, and sodium hydroxide, potassium hydroxide, etc. in water, dioxane and mixed solvents thereof. After reacting with a base such as 60 to 120 degrees for about 1 to 3 hours, the mixture was cooled and treated with acetic acid or hydrochloric acid to obtain a compound obtained by the method of filtration, extraction, evaporation, recrystallization, and a combination thereof. Get)

얻어진 일반식(Ⅶ)의 화합물을 디메틸포름아미이드, 디메틸술폭시드와 같은 극성 용매에서 몰비로 3-6배에 해당하는 포타슘플루오라이드를 사용하여 150-200도에서 3-6시간 반응시킨후 여기에 몰비로 1.5 내지 5배에 해당하는 일반식(Ⅷ)의 아민화합물과 반응시켜서 일반식(Ⅸ)의 화합물을 얻는다.The obtained compound of formula (VII) was reacted for 3-6 hours at 150-200 degrees using potassium fluoride corresponding to 3-6 times in molar ratio in polar solvent such as dimethylformamide and dimethyl sulfoxide. The compound of the general formula (VII) is obtained by reacting with an amine compound of the general formula (IV) corresponding to 1.5 to 5 times in molar ratio.

일반식(Ⅷ)의 아민화합물과의 반응은 유사하게 150-200도의 온도에서 3-6시간 정도 반응시키는 것이 바람직하며, 반응후 생성된 고체를 여과 또는 추출, 증발, 재결정, 및 이들의 혼합된 기술의 방법으로 순수한 일반식(Ⅸ)의 화합물을 얻을 수 있으며, 얻어진 일반식(Ⅸ)의 화합물은 독성이 적으며, 그램 음성균 및 그램 양성균에 탁월한 항규활성을 가진다.The reaction with the amine compound of the general formula is similarly preferably reacted for about 3-6 hours at a temperature of 150-200 degrees, and the resulting solids are filtered or extracted, evaporated, recrystallized, and mixed By the method of the technique, a pure compound of general formula can be obtained, and the obtained compound of general formula is less toxic and has excellent anti-silicone activity against gram negative bacteria and gram positive bacteria.

다름에 실시예로서 본 발명을 상세히 설명한다.The present invention will now be described in detail by way of examples.

[실시예 1]Example 1

2,3,4-트리플루오로아니린 10.0g과 디에틸 에톡시메틸렌말로네이트 14.7g을 혼합하여 140-150도의 온도에서 3시간 가열후 냉각하여 생성된 고체를 여과하여 얻은후 이 고체를 디페닐에테르 용매 존재하에서 약 1시간 정도 환류시켜 상온으로 냉각한후 생성된 고체를 여과하여 6,7,8-트리플루오로-4-히드록시퀴놀린-3-카르복실산 에틸에스테르 8.7g을 얻었다.10.0 g of 2,3,4-trifluoroaniline and 14.7 g of diethyl ethoxymethylenemalonate were mixed, heated at a temperature of 140-150 ° C. for 3 hours, and cooled to obtain a solid produced by filtration. After refluxing for about 1 hour in the presence of a phenyl ether solvent and cooling to room temperature, the resulting solid was filtered to obtain 8.7 g of 6,7,8-trifluoro-4-hydroxyquinoline-3-carboxylic acid ethyl ester.

6,7,8-트리플루오로-4-히드록시퀴놀린-3-카르복실산 에틸에스테르 5.0g, 2-브로모 프로판올 12.8g, 탄산칼륨 6.4g을 디메틸포름아마이드 50ml에 혼합하여 100도에서 24시간 환류시켜 냉각시킨후, 용매를 제거하여 생긴 농축액을 클로로포름으로 추출한후 물로 세척한다.5.0 g of 6,7,8-trifluoro-4-hydroxyquinoline-3-carboxylic acid ethyl ester, 12.8 g of 2-bromopropanol, and 6.4 g of potassium carbonate were mixed in 50 ml of dimethylformamide and mixed at 100 ° C for 24 hours. After cooling to reflux for a time, the solvent was removed and the resulting concentrate was extracted with chloroform and washed with water.

클로로포름 부분을 건조한후 감압 증류하여 용매를 제거하고 여기에 2N NaOH 90.0ml를 넣은후 2시간동안 환류시킨다.The chloroform portion was dried and then distilled under reduced pressure to remove the solvent, and 90.0 ml of 2N NaOH was added thereto, followed by reflux for 2 hours.

반응용기를 상온으로 냉각하여 초산으로 산성화시켜서 생긴 고체를 여과한후 디메틸포름아마이드로 재결정하여 순수한 6,7,8-트리플루오로-1,4-디하이드로-1-(1-히드록시프로-2-필)-4-옥소퀴놀린-3-카르복실산 3.0g을 얻었다.The reaction vessel was cooled to room temperature, acidified with acetic acid, filtered, and then recrystallized with dimethylformamide to obtain pure 6,7,8-trifluoro-1,4-dihydro-1- (1-hydroxypro- 3.0 g of 2-phil) -4-oxoquinoline-3-carboxylic acid were obtained.

6,7,8-트리플루오로-1,4-디하이드로-1-(1-히드록시프로-2-필)-4-옥소퀴놀린-3-카르복실산 2.0g 및 포타슘플루오라이드 2.3g을 디메틸포름아미드 10ml에 혼합하여 약 1시간 동안 환류시킨후 N-메틸피페라진 1.3g을 반응용기에 투입하여 약 3시간동안 환류시킨다. 반응용기를 상온으로 냉각하여 감압증류하에서 용매를 제거하고 물을 투입하여 생성된 고체를 여과하고 에탄올로 재결정하여 9-플루오로-2,3-디하이드로-3-메틸-10-(4-메틸-1-피페라지닐)-7-옥소-7H-피리도[1,2,3-de][1,4]벤즈옥사진-6-카르복실산 1.4g을 얻었다.2.0 g of 6,7,8-trifluoro-1,4-dihydro-1- (1-hydroxypro-2-fil) -4-oxoquinoline-3-carboxylic acid and 2.3 g of potassium fluoride After mixing in 10 ml of dimethylformamide and refluxing for about 1 hour, 1.3 g of N-methylpiperazine was added to the reaction vessel and refluxed for about 3 hours. The reaction vessel was cooled to room temperature, the solvent was removed under reduced pressure distillation, water was added, and the resulting solid was filtered and recrystallized with ethanol to give 9-fluoro-2,3-dihydro-3-methyl-10- (4-methyl 1.4 g of -1-piperazinyl) -7-oxo-7H-pyrido [1,2,3-de] [1,4] benzoxazine-6-carboxylic acid was obtained.

융점 : 250-257도(분해)Melting Point: 250-257 degrees (decomposition)

[실시예 2]Example 2

2,3,4-틀리클로로아닐린 12.0g과 디에틸 에톡시메틸렌말로네이트 14.9g을 혼합하여 155도의 온도에서 3시간 가열한 후 냉각하여 생성된 고체를 여과하여 얻은후 이 고체를 디페닐에테르 용매존재하에서 1시간정도 환류시키고 상온으로 냉각시킨후 생성된 고체를 여과하여 6,7,8-트리클로로-4-히드록시퀴놀린-3-카르복실산 에틸에스테르 8.5g을 얻었다.12.0 g of 2,3,4-tlychloroaniline and 14.9 g of diethyl ethoxymethylenemalonate were mixed, heated at a temperature of 155 ° C. for 3 hours, and cooled to obtain a solid produced by filtration. After refluxing for about 1 hour in the presence and cooling to room temperature, the resulting solid was filtered to obtain 8.5 g of 6,7,8-trichloro-4-hydroxyquinoline-3-carboxylic acid ethyl ester.

이 생성물 5.0g, 2-브로모프로판을 12.8g 및 탄산칼륨 6.4g을 디메틸포름아마이드 50ml에 혼합하여 100도에서 24시간 환류시킨후 냉각시키고 용매를 제거하여 얻어진 농축액을 플로로포름으로 추출한후 물로 세척한다. 클로로포름 부분을 건조한후 감압증류하여 용매를 제거하고 여기에 2N NaOH 90.0ml를 넣은후 2시간동안 환류시킨다.5.0 g of this product, 12.8 g of 2-bromopropane and 6.4 g of potassium carbonate were mixed in 50 ml of dimethylformamide, refluxed at 100 ° C for 24 hours, cooled, and the solvent was extracted. The concentrated solution was extracted with fluoroform, and extracted with water. Wash. The chloroform part is dried and distilled under reduced pressure to remove the solvent, and 90.0 ml of 2N NaOH is added thereto, followed by reflux for 2 hours.

반응용기를 상온으로 냉각하여 초산으로 산성화시켜서 얻어진 고체를 여과한후 디메틸포름아마이드로 재결정하여 순수한 6,7,8-트리플루오로-1,4-디하이드로-1-(1-히드록시프로-2-필)-4-옥소퀴놀린-3-카르복실산 3.1g을 얻었다.The reaction vessel was cooled to room temperature and acidified with acetic acid. The solid obtained was filtered and then recrystallized from dimethylformamide to obtain pure 6,7,8-trifluoro-1,4-dihydro-1- (1-hydroxypro- 3.1 g of 2-phil) -4-oxoquinoline-3-carboxylic acid were obtained.

이 생성물 2.0g 및 포타슘 플루오라이드 2.3g을 디메틸포름아마이드 10ml에 혼합하여 약 1시간 동안 환류시킨후 피페라진 1.1g과 실시예1과 같은 방법으로 반응시켜 9-플루오로-2,3-디하이드로-3-메틸-10-(4-메틸-1-피페라지닐)-7-옥소-7H-피리도[1,2,3-de][1,4]벤즈옥사진-6-카르복실산 1.4g을 얻었다.2.0 g of this product and 2.3 g of potassium fluoride were mixed in 10 ml of dimethylformamide, refluxed for about 1 hour, and then reacted with 1.1 g of piperazine in the same manner as in Example 1 to react 9-fluoro-2,3-dihydro. -3-methyl-10- (4-methyl-1-piperazinyl) -7-oxo-7H-pyrido [1,2,3-de] [1,4] benzoxazine-6-carboxylic acid 1.4 g was obtained.

융점 : 258-261도(분해)Melting Point: 258-261 Degrees (Decomposition)

[실시예 3]Example 3

실시예1에서 N-메틸피페라진 대신에 피롤리딘 0.9g을 사용한 것을 제외하고는 동일하기에 실시하여 9-플루오로-2,3-디하이드로-3-메틸-10-(4-메틸-1-피페라지닐)-7-옥소-7H-피리도[1,2,3-de][1,4]벤즈옥사진-6-카르복실산 1.3g을 얻었다.The same procedure as in Example 1 except that 0.9 g of pyrrolidine was used instead of N-methylpiperazine, 9-fluoro-2,3-dihydro-3-methyl-10- (4-methyl- 1.3 g of 1-piperazinyl) -7-oxo-7H-pyrido [1,2,3-de] [1,4] benzoxazine-6-carboxylic acid was obtained.

융점 : 268-269도(분해)Melting Point: 268-269 degrees (decomposition)

본 명세서에서 사용하는 모든 온도는 섭씨를 나타낸다.All temperatures used herein are in degrees Celsius.

Claims (2)

일반식(Ⅰ)의 화합물과 일반식(Ⅱ)의 디알킬알콕시메틸렌말로네이트와 반응시켜 일반식(Ⅲ)의 화합물을 제조한후 고리화반응을 시켜서 일반식(Ⅳ)의 화합물을 제조하고 이 화합물을 일반식(Ⅴ)의 화합물과 반응시켜 일반식(Ⅵ)의 화합물을 제조한후 가수분해시켜서 일반식(Ⅶ)의 화합물을 제조한후 이 화합물을 일반식(Ⅷ)의 화합물과 반응시킴을 특징으로 하는 일반식(Ⅸ)로 표시되는 9-할로-7-옥소-2,3-디하이드로-7H-피리도[1,2,3-de][1,4]벤즈옥사진-6-카르복실산 유도체를 제조하는 방법.A compound of formula (I) is reacted with a dialkylalkoxymethylenemalonate of formula (II) to prepare a compound of formula (III), followed by a cyclization reaction to prepare a compound of formula (IV). The compound is reacted with a compound of formula (V) to prepare a compound of formula (VI), followed by hydrolysis to produce a compound of formula (VII), and then to react with the compound of formula (VII). 9-halo-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de] [1,4] benzoxazine-6 represented by the general formula A process for preparing a carboxylic acid derivative. 제1항에서, 고리화반응을 폴리 포스포릭 산 및 폴리포스포릭 산 에스테르에서 선택된 촉매 존재하에 반응시키는 방법.The method of claim 1, wherein the cyclization is reacted in the presence of a catalyst selected from polyphosphoric acid and polyphosphoric acid esters. 상기식에서, R은 수소원자 또는 탄소수 1-6의 저급 알킬기이며, R1은 탄소수 1-2의 저급알킬기이며, X는 할로겐 원자이며, A는 단일치환된 아미노기, 이(디)치환된 아미노기 또는 환상치환된 아미노기이다.Wherein R is a hydrogen atom or a lower alkyl group having 1-6 carbon atoms, R 1 is a lower alkyl group having 1-2 carbon atoms, X is a halogen atom, A is a monosubstituted amino group, a di (di) substituted amino group or It is a cyclic substituted amino group.
KR1019910014345A 1991-08-20 1991-08-20 Process for preparing benzoxazine derivatives KR940004811B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019910014345A KR940004811B1 (en) 1991-08-20 1991-08-20 Process for preparing benzoxazine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019910014345A KR940004811B1 (en) 1991-08-20 1991-08-20 Process for preparing benzoxazine derivatives

Publications (1)

Publication Number Publication Date
KR940004811B1 true KR940004811B1 (en) 1994-06-01

Family

ID=19318804

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910014345A KR940004811B1 (en) 1991-08-20 1991-08-20 Process for preparing benzoxazine derivatives

Country Status (1)

Country Link
KR (1) KR940004811B1 (en)

Similar Documents

Publication Publication Date Title
EP0047005B1 (en) Benzoxazine derivatives
DK171967B1 (en) Quinoline Carboxylic Acid Derivatives, Process for Preparation thereof, and a Pharmaceutical Agent Containing These
KR880002353B1 (en) Quinoline compounds and process for the preparation thereof
KR0125115B1 (en) Process for preparing piperazinyl quinolone derivatives
KR940004811B1 (en) Process for preparing benzoxazine derivatives
EP0101829B1 (en) Tricyclic compounds, a process for their production and pharmaceutical compositions containing said compounds
KR960015032B1 (en) The process for preparing benzoxazine derivatives
US4826985A (en) Intermediates for preparation of racemate and optically active ofloxacin and related derivatives
KR950008317B1 (en) The preparation process of benzoxazine derivatives
JP2865761B2 (en) Benzo [b] [1,8] naphthyridine derivatives and their preparation
FI70219B (en) PROCEDURE FOR THE FRAMSTATION OF BETA-LACTAMANT BIOOTICS
KR970005310B1 (en) The process of preparing benzoxazine derivatives
KR940009792B1 (en) Process for preparing benzoxazine carboxylic acid derivatives
KR970002641B1 (en) Derivatives of quinoline carboxylic acid
KR100237142B1 (en) Method for preparing benzo[b]naphthyridines
US3882125A (en) 2,9-Dioxo-3,6 substituted thiazolo{8 5,4-f{9 {0 quinoline-8-carboxylates
NO170153B (en) PREPARATION OF 1-METHYLAMINOKINOLINCARBOXYL ACID DERIVATIVES
EP0675880B1 (en) Quinoline disulfides as intermediates
KR100494882B1 (en) A process for preparing (-)-9-Fluoro-2,3-dihydro-3(S)-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
KR940004812B1 (en) Process for preparing benzoxazine derivatives
KR100440192B1 (en) Method of preparing optical active quinolonecarboxylic acid derivatives
IL103403A (en) 6-fluoro-7-halo-1,2-dihydro-2-oxo-3-quinolinecarboxylic acid derivatives and their preparation
KR20010018722A (en) Ethyl 2,3,5-trifluoro-4-(4-methyl-1-piperazinyl)benzoylacetate and a process for preparing thereof
JPH0413356B2 (en)

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee